HHS spending $347m to boost supply of COVID-19 vaccine, treatment vials

The U.S. Dept. of Health & Human Services (HHS) and Dept. of Defense (DoD) announced a joint effort to increase manufacturing for vials earmarked for COVID-19-related drugs and vaccines.

The Biomedical Advanced Research and Development Authority (BARDA), as part of HHS, collaborated with DoD to provide funding for U.S.-based companies Corning Inc. and SiO2 Materials Science.

Get the full story at our sister site, Pharmaceutical Processing World.

Read more
  • 0

Phlow lands $354m government contract for COVID-19 medications

Phlow announced today that it received $354 million in U.S. government funding to manufacture essential medicines at risk of shortage, including those involved in the COVID-19 pandemic response.

Richmond, Va.-based Phlow’s manufacturing is being funded by the Biomedical Advanced Research and Development Authority (BARDA), part of the office of Assistant Secretary for Preparedness and Response (ASPR) at the U.S. Dept. of Health and Human Services (HHS).

Get the full story at our sister site, Drug Discovery & Development.

Read more
  • 0

HHS announces $5 million award for COVID-19 research

The U.S. Health and Human Services Dept. announced today that it will offer a $5 million award this year to support research related to COVID-19.

The new funding opportunity announcement (FOA) is set to support novel, high-impact studies evaluating the responsiveness of healthcare delivery systems, healthcare professionals and the overall U.S. healthcare system amid the COVID-19 pandemic.

HHS announced the FOA through the Agency for Healthcare Research & Quality (AHRQ), which expects to invest the $5 million for new multi-method, rapid-cycle research with the ability to produce and disseminate initial observations within six months following the award, then regularly throughout the remainder of the award period.

AHRQ noted that the funding will support critical research focused on quality, safety and value of the health system’s response to COVID-19, the role of primary care practices and professionals during this pandemic, understanding how th…

Read more
  • 0